EDAP TMS S.A.

7.40-0.0900-1.20%Vol 14.04K1Y Perf 23.60%
Aug 9th, 2022 15:57 DELAYED
BID7.41 ASK7.49
Open7.44 Previous Close7.49
Pre-Market- After-Market7.44
 - -  0.04 0.54%
Target Price
11.00 
Analyst Rating
Strong Buy 1.00
Potential %
48.65 
Finscreener Ranking
★★+     46.47
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     37.70
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     48.13
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
83.33 
Earnings Rating
Neutral
Market Cap247.65M 
Earnings Date
24th Aug 2022
Alpha0.02 Standard Deviation0.19
Beta1.34 

Today's Price Range

7.367.72

52W Range

5.007.88

5 Year PE Ratio Range

-141.0094.10

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.81%
1 Month
14.53%
3 Months
19.84%
6 Months
3.31%
1 Year
23.60%
3 Years
134.06%
5 Years
166.55%
10 Years
351.20%

TickerPriceChg.Chg.%
EDAP7.40-0.0900-1.20
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
42.40
1.30
1.30
2.10
3.51
RevenueValueIndustryS&P 500US Markets
49.76M
1.49
3.78
7.49
Earnings HistoryEstimateReportedSurprise %
Q01 2022-0.010.01200.00
Q04 2021-0.04-
Q03 20210.00-0.04-
Q02 20210.03-0.02-166.67
Q01 20210.010.03200.00
Q04 20200.100.03-70.00
Q03 2020-0.02-0.04-100.00
Q02 2020-0.08-0.0187.50
Earnings Per EndEstimateRevision %Trend
6/2022 QR-0.03-50.00Negative
9/2022 QR-0.0528.57Positive
12/2022 FY-0.080.00-
12/2023 FY-0.040.00-
Next Report Date24th Aug 2022
Estimated EPS Next Report-0.03
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume14.04K
Shares Outstanding33.47K
Shares Float33.47M
Trades Count185
Dollar Volume105.06K
Avg. Volume36.13K
Avg. Weekly Volume32.02K
Avg. Monthly Volume34.91K
Avg. Quarterly Volume41.44K

EDAP TMS S.A. (NASDAQ: EDAP) stock closed at 7.49 per share at the end of the most recent trading day (a -1.71% change compared to the prior day closing price) with a volume of 46.50K shares and market capitalization of 247.65M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 216 people. EDAP TMS S.A. CEO is Marc Oczachowski.

The one-year performance of EDAP TMS S.A. stock is 23.6%, while year-to-date (YTD) performance is 25.04%. EDAP stock has a five-year performance of 166.55%. Its 52-week range is between 5.0001 and 7.88, which gives EDAP stock a 52-week price range ratio of 83.33%

EDAP TMS S.A. currently has a PE ratio of 611.10, a price-to-book (PB) ratio of 4.17, a price-to-sale (PS) ratio of 4.84, a price to cashflow ratio of 52.10, a PEG ratio of 2.32, a ROA of 0.44%, a ROC of 0.64% and a ROE of 0.73%. The company’s profit margin is 3.51%, its EBITDA margin is 1.30%, and its revenue ttm is $49.76 Million , which makes it $1.49 revenue per share.

Of the last four earnings reports from EDAP TMS S.A., there were 1 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. EDAP TMS S.A.’s next earnings report date is 24th Aug 2022.

The consensus rating of Wall Street analysts for EDAP TMS S.A. is Strong Buy (1), with a target price of $11, which is +48.65% compared to the current price. The earnings rating for EDAP TMS S.A. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

EDAP TMS S.A. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

EDAP TMS S.A. has a Buy technical analysis rating based on Technical Indicators (ADX : 21.14, ATR14 : 0.31, CCI20 : 117.02, Chaikin Money Flow : 0.27, MACD : 0.19, Money Flow Index : 53.62, ROC : 5.20, RSI : 63.00, STOCH (14,3) : 67.40, STOCH RSI : 0.49, UO : 63.62, Williams %R : -32.60), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of EDAP TMS S.A. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

EDAP TMS S.A.

Edap TMS SAis a holding company operating in two divisions namely, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets two HIFU devices: the Ablatherm, treatment of organ-confined prostate cancer; and the Focal One, for the focal therapy of localized prostate cancer destroying targeted cancer cells only. The UDS division develops, markets, manufactures and services medical devices for the invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The business of the presence of the firm are sen Asia, France, United States and other regions.

CEO: Marc Oczachowski

Telephone: +33 472153150

Address: Parc d'Activites La Poudrette-Lamartine, Vaulx-en-Velin 69120, , FR

Number of employees: 216

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

52%48%

TipRanks News for EDAP

Thu, 19 May 2022 10:15 GMT Analysts Offer Insights on Healthcare Companies: EDAP TMS (EDAP) and TCR2 Therapeutics (TCRR)

- TipRanks. All rights reserved.

Mon, 04 Apr 2022 10:18 GMT EDAP TMS (EDAP) Receives a Buy from H.C. Wainwright

- TipRanks. All rights reserved.

News

Stocktwits